| ID Source | ID |
|---|---|
| PubMed CID | 6441422 |
| MeSH ID | M0275605 |
| Synonym |
|---|
| 3,4-didehydroretinyl acetate |
| [(2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)nona-2,4,6,8-tetraenyl] acetate |
| 602i50fx07 , |
| 20008-04-2 |
| retinol, 3,4-didehydro-, acetate |
| unii-602i50fx07 |
| dehydroretinyl acetate-d3 |
| 3,4-didehydroretinol acetate-d3 |
| 3,4-didehydroretinol acetate |
| 3-dehydro retinol acetate |
| Q27263148 |
| (2e,4e,6e,8e)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)nona-2,4,6,8-tetraen-1-yl acetate |
| Excerpt | Relevance | Reference |
|---|---|---|
| " In dosed dams, (1) Liver concentrations of A1 and A2 increased with the doses of A1 and A2, respectively, (2) RA had little effect on liver A1 except for an increase at the highest toxic dose, and (3) A2 showed a sparing effect on liver A1." | ( Comparative embryolethality and teratogenicity of the all-trans isomers of retinoic acid, 3,4-didehydroretinyl acetate, and retinyl acetate in pregnant rats. Duitsman, PK; Olson, JA, 1996) | 0.52 |
| "The modified-relative-dose-response (MRDR) test, which requires a blood sample after dosing with 3,4-didehydroretinyl acetate (DRA), has been used to determine vitamin A (VA) status of individuals and groups worldwide." | ( The modified-relative-dose-response values in serum and milk are positively correlated over time in lactating sows with adequate vitamin A status. Li, J; Surles, RL; Tanumihardjo, SA, 2006) | 0.55 |
| "5 d) from these sows were weaned onto a VA-free diet for 1 wk, assigned to 4 groups, and dosed orally with 0, 26." | ( Vitamin A concentrations in piglet extrahepatic tissues respond differently ten days after vitamin A treatment. Sun, T; Surles, RL; Tanumihardjo, SA, 2008) | 0.35 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.43) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (20.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||